|  | Up a level | 
    Wouters, Olivier J.  ORCID: 0000-0002-2514-476X, Vogel, Matthew, Feldman, William B., Beall, Reed F., Kesselheim, Aaron S. and Tu, S. Sean 
  
(2024)
Differential legal protections for biologics vs. small-molecule drugs in the US.
    JAMA, 332 (24).
     2101 - 2108.
     ISSN 0098-7484
ORCID: 0000-0002-2514-476X, Vogel, Matthew, Feldman, William B., Beall, Reed F., Kesselheim, Aaron S. and Tu, S. Sean 
  
(2024)
Differential legal protections for biologics vs. small-molecule drugs in the US.
    JAMA, 332 (24).
     2101 - 2108.
     ISSN 0098-7484
  
  
    Feldman, William B., Tu, S. Sean, Alhiary, Rasha, Kesselheim, Aaron S. and Wouters, Olivier J.  ORCID: 0000-0002-2514-476X 
  
(2023)
Manufacturer revenue on inhalers after expiration of primary patents, 2000-2021.
    JAMA, 329 (1).
     87 - 89.
     ISSN 0098-7484
ORCID: 0000-0002-2514-476X 
  
(2023)
Manufacturer revenue on inhalers after expiration of primary patents, 2000-2021.
    JAMA, 329 (1).
     87 - 89.
     ISSN 0098-7484
  
  
    Wouters, Olivier J.  ORCID: 0000-0002-2514-476X, Feldman, William B. and Tu, S. Sean 
  
(2022)
Product hopping in the drug industry — lessons from Albuterol.
    New England Journal of Medicine, 387 (13).
     1153 - 1156.
     ISSN 0028-4793
ORCID: 0000-0002-2514-476X, Feldman, William B. and Tu, S. Sean 
  
(2022)
Product hopping in the drug industry — lessons from Albuterol.
    New England Journal of Medicine, 387 (13).
     1153 - 1156.
     ISSN 0028-4793